Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Feb;8(2):122-134.
doi: 10.1016/S2352-4642(23)00289-4. Epub 2023 Dec 15.

School bullying in children and adolescents with neurodevelopmental and psychiatric conditions: a systematic review and meta-analysis

Affiliations
Meta-Analysis

School bullying in children and adolescents with neurodevelopmental and psychiatric conditions: a systematic review and meta-analysis

Renzo Abregú-Crespo et al. Lancet Child Adolesc Health. 2024 Feb.

Abstract

Background: Bullying is a common form of violence among children and adolescents. Young people with neurodevelopmental or psychiatric conditions might have an increased risk of bullying victimisation and perpetration. We aimed to assess the odds of bullying involvement and its association with mental health measures in these populations.

Methods: In this systematic review and meta-analysis, we searched PubMed, ERIC, Psychology and Behavioural Sciences Collection, Web of Science Core Collection, PsycArticles, and PsycInfo databases from inception up to Aug 8, 2023, and included articles reporting data on bullying outcomes of current bullying (within the past year) among children and adolescents (aged 4-17 years) with a diagnosis of a neurodevelopmental or psychiatric condtion provided by a health professional. Bullying type was classified as traditional (physical, verbal, or relational) or as cyberbullying (intentional and repeated harm inflicted through electronic devices and social media), and bullying involvement was classified as victimisation, perpetration, and perpetration-victimisation. Mental health measures were collected and the associations with bullying involvement assessed. We used random-effects meta-analyses to estimate prevalence and odds ratios (ORs) for bullying involvement. Heterogeneity was assessed using the I2 statistic, and publication bias was tested with Egger's regression. This study is registered with PROSPERO, CRD42021235043.

Findings: We included 212 studies in the meta-analysis. The total sample comprised 126 717 cases (mean age 12·34 years [SD 1·82], 37·6% girls) and 504 806 controls (12·5 years [SD 1·86], 47·6% girls). For traditional bullying, the pooled prevalence was 42·2% (95% CI 39·6-44·9) for victimisation, 24·4% (22·6-26·3) for perpetration, and 14·0% (11·4-17·1) for perpetration-victimisation. For cyberbullying, the prevalence was 21·8% (16·0-28·9) for victimisation, 19·6% (13·4-27·7) for perpetration, and 20·7% (8·4-42·6) for perpetration-victimisation. Compared with controls, young people with neurodevelopmental or psychiatric conditions were more likely to be involved in traditional and cyberbullying as a victim (OR 2·85 [95% CI 2·62-3·09] and 2·07 [1·63-2·61]), perpetrator (2·42 [2·20-2·66] and 1·91 [1·60-2·28]), and perpetrator-victim (3·66 [2·83-4·74] and 1·85 [1·05-3·28]). Bullying involvement was associated with higher scores in mental health measures in young people with neurodevelopmental or psychiatric conditions, particularly internalising symptoms and externalising symptoms.

Interpretation: Our study underscores bullying involvement as a prevalent risk factor in young people with neurodevelopmental or psychiatric conditions that might add to their disease burden through its negative effects on mental health. Interventions targeting these vulnerable populations are warranted to improve their mental health and their future social integration.

Funding: Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, and Consorcio Centro de Investigación Biomédica en Red.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests CA has been a consultant to or has received honoraria or grants from Acadia AMGEN, Angelini, AstraZeneca, Bristol-Myers Squibb, Caja Navarra, Comunidad de Madrid, Dainippon Pharma, Exeltis, Fundación Alicia Koplowitz, Geodon Richter, Instituto de Salud Carlos III, Jansssen-Cilag, Lundbeck, Ministerio Educación, Otsuka, Roche, Sage, Sanofi, Schering Plough, Shire, Stanley Foundation, Sumitomo, Sunovion, Takeda, and Teva. DF has received funding as an advisor or speaker from Angelini, Casen Recordati, Eisai, Lundbeck, Otsuka, and Rovi. He has also received research funds from the Instituto de Salud Carlos III, Fundación Alicia Koplowitz, and Fundación La Caixa. CMD-C has received honoraria from Angelini and support to attend conferences from Janssen and Angelini. She has also received research funds from the Instituto de Salud Carlos III and European Comission. MA has held a Río Hortega grant from Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation). All other authors declare no competing interests.

Comment in

Publication types

LinkOut - more resources